C

Coherus BioSciences

340 employees

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
biotechnology and biosimilars
Medical

Date founded

2010

Funding rounds raised

Total raised

$100M

from 12 investors over 12 rounds

C

Coherus BioSciences raised $100M on January 7, 2022

Investors: Pharmakon Advisors, LP

C

Coherus BioSciences raised undisclosed on November 27, 2020

Investors: Lord, Abbett & Co. LLC

C

Coherus BioSciences raised $75M on January 8, 2019

Investors: HealthCare Royalty Partners

C

Coherus BioSciences raised $55M on May 19, 2014

Investors: VIVA Capital, Vivo Capital, Lilly Ventures, Helix Ventures, Sofinnova Ventures, Russia technology fund, Venrock, RA Capital Management, L.P. and KKR & Co. Inc.

C

Coherus BioSciences raised $28M on July 25, 2013

Investors: Helix Ventures

FAQ